Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 93 a 112 di 209
Titolo Data di pubblicazione Autore(i) File
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 1-gen-2015 Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Galli, Daniela; Martini, Silvia; Pozzi, Giulia; Gildone, Maria; Albanese, Cristina; Bonomini, Sabrina; Crugnola, Monica; Craviotto, Luisa; Aversa, Franco; Vitale, Marco
Increased TG lymphocytes in a case of Congenital Hypoplastic Anemia (Blackfan-Diamond Syndrome) 1-gen-1980 CORNAGLIA FERRARIS, P.; Mori, P. G.; Debernardi, B.; Pasino, M.; Ghio, R.; Sitia, Roberto; Massimo, L.
Infliximab treatment for steroid-refactory acutes graft-versus-host disease 1-gen-2004 Patriarca, F; Sperotto, A; Damiani, D; Morreale, G; Bonifazi, F; Olivieri, A; Ciceri, Fabio; Milone, G; Cesaro, S; Bandini, G; Dini, G; Corradini, P; Fanin, R.
Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low count monoclonal B cell lymphocytosis 1-gen-2021 Agathangelidis, Andreas; Galigalidou, Chrysi; Scarfò, Lydia; Moysiadis, Theodoros; Rovida, Alessandra; Gounari, Maria; Psomopoulos, Fotis; Ranghetti, Pamela; Galanis, Alex; Davi, Frederic; Stamatopoulos, Kostas; Chatzidimitriou, Anastasia; Ghia, Paolo
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS 1-gen-2014 Cottini, F; Hideshima, T; Xu, C; Ponzoni, M; Richardson, P; Cappio, Fc; Anderson, K; Tonon, G
Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go? 1-gen-2016 Pospisilova, S; Sutton, La; Malcikova, J; Tausch, E; Rossi, D; Montserrat, E; Moreno, C; Stamatopoulos, K; Gaidano, G; Rosenquist, R; Ghia, P
INTENSIVE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: A SINGLE CENTER EXPERIENCE 1-gen-2009 Crotta, A; Tassara, M; Messina, C; Malato, S; Ciceri, Fabio; Bernardi, M.
Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis 1-gen-1989 Ferrero, E; Manfredi, ANGELO ANDREA M. A.; Bianchi, E; Schönheit, A; Sabbadini, Mg; Rugarli, C.
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma 1-gen-2023 Khwaja, J.; Kirkwood, A. A.; Isbell, L. K.; Steffanoni, S.; Goradia, H.; Pospiech, L.; Fail, T.; Nicholson, E.; Fletcher, K.; Linton, K. M.; Parsons, K. E.; Elmusharaf, N.; Eccersley, L.; Eyre, T. A.; Chaganti, S.; Smith, J.; Thakrar, N.; Kutilina, A.; Calimeri, T.; Martinez-Calle, N.; El-Sharkawi, D.; Osborne, W.; Illerhaus, G.; Fox, C. P.; Ferreri, A. J. M.; Schorb, E.; Cwynarski, K.
Iron increases the susceptibility of multiple myeloma cells to bortezomib 1-gen-2013 Campanella, A; Santambrogio, P; Fontana, F; Frenquelli, M; Cenci, S; Marcatti, M; Sitia, Roberto; Tonon, G; Camaschella, Clara
Iron refractory iron deficiency anemia 1-gen-2013 DE FALCO, L; Sanchez, M; Silvestri, L; Kannengiesser, C; Muckenthaler, Mu; Iolascon, A; Gouya, L; Camaschella, Clara; Beaumont, C.
Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient 1-gen-2006 Ponzoni, Maurilio; Ciceri, Fabio; Crocchiolo, R; Famoso, G; Doglioni, C.
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders 1-gen-2008 Angelucci, E; Barosi, G; Camaschella, Clara; Cappellini, Md; Cazzola, M; Galanello, R; Marchetti, M; Piga, A; Tura, S.
JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyterich large B-cell lymphoma 1-gen-2019 Schuhmacher, B.; Bein, J.; Rausch, T.; Benes, V.; Tousseyn, T.; Vornanen, M.; Ponzoni, M.; Thurner, L.; Gascoyne, R.; Steidl, C.; Kuppers, R.; Hansmann, M. -L.; Hartmann, S.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: A FIL study 1-gen-2020 Ferrero, S.; Rossi, D.; Rinaldi, A.; Bruscaggin, A.; Spina, V.; Eskelund, C. W.; Evangelista, A.; Moia, R.; Kwee, I.; Dahl, C.; Di Rocco, A.; Stefoni, V.; Diop, F.; Favini, C.; Ghione, P.; Mahmoud, A. M.; Schipani, M.; Kolstad, A.; Barbero, D.; Novero, D.; Paulli, M.; Zamo, A.; Jerkeman, M.; Da Silva, M. G.; Santoro, A.; Molinari, A.; Ferreri, A.; Gronbaek, K.; Piccin, A.; Cortelazzo, S.; Bertoni, F.; Ladetto, M.; Gaidano, G.
LEUKEMIA RELAPSE AFTER ALLOGENENIC HSCT DISPLAYS A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION 1-gen-2015 Toffalori, C; Riba, M; Zito, L; Oliveira, G; Bucci, G; Barcella, M; Spinelli, O; Crucitti, L; Cieri, N; Cittaro, D; Lazarevic, D; Peccatori, J; Bernardi, M; Bonini, C; Rambaldi, A; Barlassina, C; Stupka, E; Bianchi, M; Ciceri, F; Fleischhauer, K; Vago, L
LEUKEMIA RELAPSES AFTER ALLOGENENIC HSCT DISPLAY A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION 1-gen-2015 Toffalori, C; Riba, M; Zito, L; Oliveira, G; Bucci, G; Barcella, M; Spinelli, O; Crucitti, L; Cieri, N; Cittaro, D; Lazarevic, D; Peccatori, J; Bernardi, M; Bonini, C; Rambaldi, A; Barlassina, C; Stupka, E; Bianchi, M; Ciceri, F; Fleischhauer, K; Vago, L
Leukocyte counts in professional football players 1-gen-2003 A., Dolci; G., Nanni; G., Sisca; B., Costantino; A., Baldari; G., Palaia; Banfi, Giuseppe
Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia 1-gen-2006 DE FRANCESCHI, L; Daraio, F; Filippini, A; Carturan, S; Muchitsch, Em; Roetto, A; Camaschella, Clara
Long-term outcome of RIC-allo SCT for myeloma 1-gen-2007 Montefusco, V; Ciceri, Fabio; Peccatori, J; Farina, L; Olivieri, A; Hoenstaufen, K; Deliliers, Gl; Gianni, Am; Bregni, M; Corradini, P.
Mostrati risultati da 93 a 112 di 209
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile